Bahrain Pharma
Bahrain Pharma is a privately held pharmaceutical manufacturer in Hidd, Bahrain, producing softgel capsules, vitamin gummies, and syrups for healthcare consumers while offering GMP-compliant contract manufacturing, R&D, packaging, and product commercialization services to pharmaceutical companies across the GCC.
- Company typePrivate
- Founded2010
- HeadquartersHidd, Bahrain
- Headcount51–100
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Bahrain Pharma does
Bahrain Pharma, legally Bahraini International Medicine Manufacturing Company, is a privately held pharmaceutical manufacturer headquartered at the Bahrain International Investment Park in Hidd, Kingdom of Bahrain. It operates a single manufacturing and distribution site from which it produces softgel capsules, vitamin gummies (for adults and children), and cough and vitamin syrups. The company describes itself as the sole manufacturer and distributor of softgel vitamins, mineral supplements, vitamin gummies, and syrups within Bahrain, and markets itself as a leading healthcare products manufacturer across the GCC region.
The business operates a hybrid model combining proprietary branded consumer health products with B2B contract manufacturing services. Revenue streams span hardware sales of its own softgel, gummy, and syrup SKUs alongside professional services covering contract manufacturing, R&D (formulation development, nutritional science, taste and texture optimization), product commercialization (market analysis, brand development, distribution support), and packaging services (PET and glass bottles, blister packaging, gummies packaging). Manufacturing is conducted under GMP compliance, with the "Bahrain Pharma" and "BP" trademarks registered to the parent entity.
Go-to-market relies on enterprise field sales for B2B contract manufacturing clients, complemented by a regional channel of distributors, wholesalers, and retailers for consumer product distribution across the GCC. The company also maintains a multi-channel digital presence (website, WhatsApp, Facebook, Instagram, LinkedIn) and a dedicated business development contact for partnership inquiries. Pricing is not publicly disclosed and is quoted per project based on formulation, volume, and packaging requirements.
Bahrain Pharma firmographics
Firmographics- Name
- Bahrain Pharma
- Legal name
- Bahraini International Medicine Manufacturing Company
- Website
- https://bahrain-pharma.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Bahrain Pharma is a privately held pharmaceutical manufacturer in Hidd, Bahrain, producing softgel capsules, vitamin gummies, and syrups for healthcare consumers while offering GMP-compliant contract manufacturing, R&D, packaging, and product commercialization services to pharmaceutical companies across the GCC.
- Ownership category
- akta.pro rank
Bahrain Pharma industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Packaging and Labeling Services (56191)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Vitamins & Minerals (Single Nutrients) (CRADAGAB)
- akta.pro secondary industries
- Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules) (IMALAIAA), Pharmaceutical & Medical Device Packaging (GMP, Tamper-Evident, Cold-Chain Packs) (TLAIAGAI)
Keywords
Where Bahrain Pharma is headquartered
LocationHeadquarters
- HQ city
- Hidd
- HQ country
- Bahrain
- HQ region
- Middle East
Offices1 record
Markets served
Bahrain Pharma business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Contract Manufacturing Services: Bahrain Pharma provides contract manufacturing services for softgel products to external pharmaceutical companies. Their commitment to strict quality standards, cutting-edge technology, and seamless project management ensures successful collaboration with partners requiring manufacturing capabilities.
- Proprietary Pharmaceutical Products: Manufacturing and distribution of proprietary pharmaceutical products including softgel vitamins, mineral supplements, vitamin gummies for adults and kids, and cough and vitamin syrups.
- Product Commercialization Services: Comprehensive strategies for bringing pharmaceutical products to market including market analysis, strategic planning, brand development, marketing, distribution and sales support.
- Packaging Services: Comprehensive packaging services for oral bottles (PET and glass), supplement bottles, blister packaging for capsules, and gummies packaging in clear PET bottles.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels3 records
Bahrain Pharma product offering
Product offeringCore offering
Bahrain Pharma manufactures and distributes proprietary pharmaceutical products (softgel capsules, vitamin gummies for adults and children, and cough/vitamin syrups) and provides B2B services including contract manufacturing, research and development, product commercialisation, and packaging services for other pharmaceutical companies in the GCC region.
Product overview
Bahrain Pharma is the leading pharmaceutical manufacturer in the Kingdom of Bahrain, operating as a single unified manufacturing and distribution operation. The company produces a portfolio of pharmaceutical products including Softgel Capsules (Vitamin A&D formulations), Vitamin Gummies for both Kids and Adults, and Syrups (cough and vitamin formulations). The product portfolio is supported by four key service offerings: Contract Manufacturing Services (for third-party pharmaceutical formulations), Research and Development Services (formulation, nutritional science, efficacy studies), Product Commercialisation Services (market strategy, distribution, sales), and Packaging Services (oral bottles, blister packaging, gummies packaging). The company positions itself as the sole manufacturer and distributor of high-quality softgel vitamins, mineral supplements, vitamin gummies, and cough/vitamin syrups in Bahrain.
Differentiator
Problem solved
Functional benefit
Brands
- BP: BP trademark - registered trade name and logo used by Bahraini International Medicine Manufacturing Company
Products and services
- Softgel Capsules
Companies that use Bahrain Pharma
Customer profileSegments3 records
Ideal customer profiles3 records
Bahrain Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Bahrain Pharma partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights4 records
Bahrain Pharma competitors and assessment
Company assessmentBroad incumbents
- Cipla: Cipla is a major Indian multinational pharma manufacturer with extensive presence in MENA markets, producing generics, OTC, and supplements. Comparable as a manufacturer relying on regional distribution, with dosage-form overlap in softgels and syrups.
- Hikma Pharmaceuticals: Hikma is a major MENA-headquartered pharmaceutical company with broad branded, generic, and injectables portfolios across the region. While much larger and more diversified than Bahrain Pharma, it serves the same regional customer base and competes for similar GCC distribution channels.
- Aurobindo Pharma: Aurobindo is a large Indian generic and OTC manufacturer with significant export presence in the MENA/GCC region. Comparable in being a high-volume API/finished-dose manufacturer leveraging cost-efficient GMP facilities for export markets.
- Catalent: Catalent is a global contract development and manufacturing organization (CDMO) with softgel encapsulation as a flagship capability. Direct functional peer to Bahrain Pharma's contract manufacturing and softgel technology stack, but at vastly larger scale.
Emerging players
- Sirio Pharma: Sirio is a China-based CDMO specializing in gummies, softgels, and liquid dosage forms with growing international footprint. Comparable to Bahrain Pharma's contract manufacturing and gummy/softgel/syrup capabilities, particularly relevant as a peer in the supplements CDMO space.
Direct peers
- Neopharma: Neopharma is a UAE-based pharmaceutical manufacturer with capabilities across tablets, capsules, liquids, and injectables, plus contract manufacturing services. Direct peer on GCC-based pharma manufacturing with CDMO offerings.
- Gulf Pharmaceutical Industries (Julphar): Julphar is one of the largest pharmaceutical manufacturers in the GCC (UAE-based), producing a broad portfolio of dosage forms including softgels, syrups, and injectables. It is the closest regional comp to Bahrain Pharma by both geography and dosage-form coverage, with strong distribution across the GCC.
- Tabuk Pharmaceuticals: Tabuk is a leading Saudi private pharmaceutical company with branded generics, OTC, and consumer health products including syrup and softgel dosage forms. Comparable in product mix (vitamins, OTC) and in being a GCC-headquartered manufacturer pursuing regional expansion.
- Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO): SPIMACO is a leading Saudi pharmaceutical manufacturer producing generics and OTC products across multiple dosage forms (tablets, capsules, syrups, creams). Comparable to Bahrain Pharma in regional positioning, GMP manufacturing, and emphasis on local-market supply security.
Regional players
- EIPICO (Egyptian International Pharmaceutical Industries Company): EIPICO is one of the largest pharmaceutical manufacturers in the MENA region, based in Egypt. Comparable as a regional manufacturer with broad dosage-form coverage and export reach across the Arab world, including GCC markets where Bahrain Pharma also operates.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Bahrain Pharma social profiles
Digital presenceBahrain Pharma compliance and trust
Trust signalCompliance1 record
Bahrain Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bahrain Pharma leadership team
Management profileNumber of profiles
Bahrain Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bahrain Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bahrain Pharma
What does Bahrain Pharma do?
Bahrain Pharma manufactures and distributes proprietary pharmaceutical products (softgel capsules, vitamin gummies for adults and children, and cough/vitamin syrups) and provides B2B services including contract manufacturing, research and development, product commercialisation, and packaging services for other pharmaceutical companies in the GCC region.
Is Bahrain Pharma a public or private company?
Bahrain Pharma is a private company. It is classified as unknown and is currently operating.
When was Bahrain Pharma founded?
Bahrain Pharma was founded in 2010. It employs 51 to 100 people.
Where is Bahrain Pharma based?
Bahrain Pharma is headquartered in Hidd, Bahrain, in the Middle East region.
How does Bahrain Pharma make money?
Four revenue lines are on record. Contract Manufacturing Services are the primary driver. The others are proprietary Pharmaceutical Products, product Commercialization Services and packaging Services.
Who are Bahrain Pharma's main competitors?
Broad incumbents on record are Cipla, Hikma Pharmaceuticals, Aurobindo Pharma and Catalent. Sirio Pharma is listed as an emerging player. Direct peers are Neopharma, Gulf Pharmaceutical Industries (Julphar), Tabuk Pharmaceuticals and Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO). EIPICO (Egyptian International Pharmaceutical Industries Company) is listed as a regional player.
Does Bahrain Pharma have an API?
No public API is recorded for Bahrain Pharma.
What industry is Bahrain Pharma in?
Bahrain Pharma's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is CRADAGAB, Vitamins & Minerals (Single Nutrients), with a secondary code of IMALAIAA, Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules). Its NAICS code is 325412 and its SIC code is 2833.